UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Age does not impair the efficacy of immunochemotherapy in patients with metastatic renal carcinoma

Critical reviews in oncology/hematology, 2005-09, Vol.55 (3), p.193-199

2005

Volltextzugriff (PDF)

Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma

Journal of clinical oncology, 1995-02, Vol.13 (2), p.497-501

1995

Volltextzugriff (PDF)

Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma

Cancer biotherapy & radiopharmaceuticals, 2008-02, Vol.23 (1), p.129-134

2008

Volltextzugriff (PDF)

Interleukin-2 Based Home Therapy of Metastatic Renal Cell Carcinoma: Risks and Benefits in 215 Consecutive Single Institution Patients

The Journal of urology, 1996, Vol.155 (1), p.19-25

1996

Volltextzugriff (PDF)

Adjuvant treatment of locally advanced renal cancer with autologous virus-modified tumor vaccines

World journal of urology, 1995, Vol.13 (3), p.171

1995

Volltextzugriff (PDF)

Pharmacokinetics of recombinant human interleukin‐2 in advanced renal cell carcinoma patients following subcutaneous application

British journal of clinical pharmacology, 1998-07, Vol.46 (1), p.5-10

1998

Volltextzugriff (PDF)

Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma

Journal of clinical oncology, 1995-10, Vol.13 (10), p.2679-2680

1995

Volltextzugriff (PDF)

Metastatic renal carcinoma long-term survivors treated with s.c. interferon-alpha and s.c. interleukin-2

Cancer biotherapy & radiopharmaceuticals, 2005-08, Vol.20 (4), p.410-416

2005

Volltextzugriff (PDF)

Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.529-533

1999

Volltextzugriff (PDF)

Cytokines and tumor vaccination

Cancer biotherapy & radiopharmaceuticals, 1996-10, Vol.11 (5), p.315

1996

Volltextzugriff (PDF)

Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid

World journal of urology, 1995, Vol.13 (3), p.174

1995

Volltextzugriff (PDF)

Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies

The Lancet (British edition), 1990-06, Vol.335 (8704), p.1509-1512

1990

Volltextzugriff (PDF)

Linomide and interleukin-2 in patients with advanced renal cell carcinoma

Cancer biotherapy & radiopharmaceuticals, 1996-10, Vol.11 (5), p.319

1996

Volltextzugriff (PDF)

In vivo tumor necrosis factor-alpha as indicator of biologic and clinical response to low-dose SC recombinant interleukin 2

Anticancer research, 1995-01, Vol.15 (1), p.127

1995

Volltextzugriff (PDF)

Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alpha

Annals of oncology, 1990-09, Vol.1 (5), p.377-378

1990

Volltextzugriff (PDF)

In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2

Natural immunity, 1992-05, Vol.11 (3), p.133

1992

Volltextzugriff (PDF)

Pretreatment natural killer antigen density correlates to clinical response in tumor patients receiving long-term subcutaneous recombinant interleukin-2 and recombinant interferon-alpha

Molecular biotherapy, 1992-12, Vol.4 (4), p.170

1992

Volltextzugriff (PDF)

Alpha-interferon and interleukin-2 in renal cell carcinoma : studies in nonhospitalized patients

Seminars in oncology, 1991-10, Vol.18 (5), p.108-112

1991

Volltextzugriff (PDF)

Interferon-α/5-fluorouracil: a novel outpatient chemo/immunotherapy for progressive metastatic renal cell carcinoma

Cancer biotherapy, 1995, Vol.10 (1), p.21-24

1995

Volltextzugriff (PDF)

Biological monitoring of low-dose interleukin 2 in humans : soluble interleukin 2 receptors, cytokines, and cell surface phenotypes

Cancer research (Chicago, Ill.), 1991-12, Vol.51 (23), p.6312-6316

1991

Volltextzugriff (PDF)

In vivo distribution of integrins in renal cell carcinoma : integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasis

Cancer biotherapy, 1995, Vol.10 (4), p.287-292

1995

Volltextzugriff (PDF)

Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma

Medizinische Klinik (München. 1983), 1996-04, Vol.91 Suppl 3, p.38

1996

Volltextzugriff (PDF)

A comparison of 2 modes of administration of recombinant interleukin-2: continuous intravenous infusion alone versus subcutaneous administration plus interferon alpha in patients with advanced renal cell carcinoma

Cancer biotherapy, 1993, Vol.8 (2), p.123-136

1993

Volltextzugriff (PDF)

Active specific immunotherapy of renal cell carcinoma : Cellular and humoral immune responses

Cancer biotherapy & radiopharmaceuticals, 1997-01, Vol.12 (3), p.157-165

1997

Volltextzugriff (PDF)

European studies of interleukin-2 in metastatic renal cell carcinoma

Seminars in oncology, 1993-12, Vol.20 (6), p.22-26

1993

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaKidney Neoplasms - Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(32)

Sprache

Englisch
(31)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Carcinoma, Renal Cell - Therapy
(32)
Humans
(32)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Aged
(23)
Female
(23)
Male
(23)
Middle Aged
(23)
Interleukin-2 - Administration & Dosage
(21)
Immunotherapy
(19)
Oncology
(19)
Adult
(18)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Interleukin-2 - Therapeutic Use
(16)
Antineoplastic Agents
(15)
Pharmacology. Drug Treatments
(15)
Injections, Subcutaneous
(14)
Recombinant Proteins - Administration & Dosage
(14)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Age does not impair the efficacy of immunochemotherapy in patients with metastatic renal carcinoma

Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma

Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma

Interleukin-2 Based Home Therapy of Metastatic Renal Cell Carcinoma: Risks and Benefits in 215 Consecutive Single Institution Patients

Adjuvant treatment of locally advanced renal cancer with autologous virus-modified tumor vaccines

Pharmacokinetics of recombinant human interleukin‐2 in advanced renal cell carcinoma patients following subcutaneous application

Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma

Metastatic renal carcinoma long-term survivors treated with s.c. interferon-alpha and s.c. interleukin-2

Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell Cancer

Cytokines and tumor vaccination

Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid

Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies

Linomide and interleukin-2 in patients with advanced renal cell carcinoma

In vivo tumor necrosis factor-alpha as indicator of biologic and clinical response to low-dose SC recombinant interleukin 2

Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alpha

In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2

Pretreatment natural killer antigen density correlates to clinical response in tumor patients receiving long-term subcutaneous recombinant interleukin-2 and recombinant interferon-alpha

Alpha-interferon and interleukin-2 in renal cell carcinoma : studies in nonhospitalized patients

Interferon-α/5-fluorouracil: a novel outpatient chemo/immunotherapy for progressive metastatic renal cell carcinoma

Biological monitoring of low-dose interleukin 2 in humans : soluble interleukin 2 receptors, cytokines, and cell surface phenotypes

In vivo distribution of integrins in renal cell carcinoma : integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasis

Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma

A comparison of 2 modes of administration of recombinant interleukin-2: continuous intravenous infusion alone versus subcutaneous administration plus interferon alpha in patients with advanced renal cell carcinoma

Active specific immunotherapy of renal cell carcinoma : Cellular and humoral immune responses

European studies of interleukin-2 in metastatic renal cell carcinoma

Aktive Filter

Suchergebnisse filtern